- S Asscher
- St George's Hospital Medical School, London SW17 0RE.
EDITOR, - C L Crawford has raised some questions about the prescription of thalidomide on a named patient basis to patients with leprosy in Britain.1 He wrote to me when I was chairman of the Committee on the Safety of Medicines to ask what information a supplier is required by law to provide with thalidomide when supplying the drug to …
Sign in
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
Easy Read
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Mendeley
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Re: Emergency admissions for diabetes fall by almost 7% in integrated care pilot scheme
Published 24 May 2012
Re: Television shows and education about sexually transmitted infections: no laughing matter
Published 24 May 2012
Re: The scatter of research: cross sectional comparison of randomised trials and systematic reviews across specialties
Published 24 May 2012
Re: Outcomes of elective induction of labour compared with expectant management: population based study
Published 24 May 2012
Reply to Anne Szarewski and Diana Mansour
Published 24 May 2012
Most responses
The psychiatric oligarchs who medicalise normality (8 responses)
Published 2 May 2012
Are doctors justified in taking industrial action in defence of their pensions? No (8 responses)
Published 8 May 2012 - 12:21
Are doctors justified in taking industrial action in defence of their pensions? Yes (8 responses)
Published 8 May 2012 - 12:21
Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10 (8 responses)
Published 10 May 2012 - 23:32
The hardest thing: admitting error (7 responses)
Published 2 May 2012 - 12:27